- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03112317
Mild Hypothermia Influence on Patient Outcome in Major Abdominal Surgery
Does Mild Hypothermia Increase Intra-Operative Blood Loss and Surgical Site Infections in Major Abdominal Surgery?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study evaluates associations between patients' core temperature during surgery and intra-operative blood loss, and to SSI. Additionally, the investigators observe the use of hypothermia prevention measures in operating theaters, use of surgical safety checklists. SSI is registered at discharge from hospital and up to 30 days post-discharge.
The goal of the study is to contribute to focus on prevention of even mild hypothermia in surgery.
This study is of interest for healthcare personnel as operating room nurses, surgeons, nurse anaesthetists, anaesthesiologists, ward nurses, post anaesthetic care unit nurses, and other healthcare staff involved in the in-hospital surgical pathway.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bergen, Norway, 5021
- Haukeland University Hospital
-
-
Hordaland
-
Bergen, Hordaland, Norway, 5021
- Haukeland University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients (men or women) above 18 years, undergoing abdominal or gynecological surgery with laparotomy or laparoscopy.
Exclusion Criteria:
- Surgical procedures with intentional reduction of core temperature. Patients under the age of 18.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hypothermia
Patients with mild hypothermia at start of the surgery
|
Patients are routinely warmed with forced air warming blankets, regular blankets, pre warmed intravenous fluid.
Routines are ensured with use of the WHO Surgical Safety Checklist.
The intervention is the use of operating theatre care measures to prevent mild hypothermia in surgical patients.
Other Names:
|
|
Normothermia
Patients with normal core temperature at start of surgery.
|
Patients are routinely warmed with forced air warming blankets, regular blankets, pre warmed intravenous fluid.
Routines are ensured with use of the WHO Surgical Safety Checklist.
The intervention is the use of operating theatre care measures to prevent mild hypothermia in surgical patients.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intra-operative blood loss (mL) in surgical patients
Time Frame: Within the surgical procedure
|
Bleeding that occur during the surgical procedure
|
Within the surgical procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peri-operative blood loss (registered by ICD-10 codes)
Time Frame: Within the duration of the surgical procedures, an average of 2.5 hours
|
Bleeding requiring blood transfusion peri-operatively
|
Within the duration of the surgical procedures, an average of 2.5 hours
|
|
Number of patients with Surgical Site Infections after surgery
Time Frame: Up to 30 days after discharge from hospital
|
Post-operative surgical site infections present before discharge from hospital
|
Up to 30 days after discharge from hospital
|
|
Number of patients with Surgical Site Infection
Time Frame: Up to 30 days after discharge from hospital
|
Post-operative surgical site infection present after discharge from hospital
|
Up to 30 days after discharge from hospital
|
|
Days admitted in hospital
Time Frame: Hospital stay up to 13 days on average
|
Length of stay in hospital
|
Hospital stay up to 13 days on average
|
|
Hours admitted in post operative care unit (PACU)
Time Frame: On average up to 14 hours
|
Length of stay in PACU
|
On average up to 14 hours
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Arvid S Haugen, PhD, MSc, Haukeland University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REK Vest (2016/2193)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Data/Documents
-
Study Protocol
Information identifier: REC West (2016-2193)Information comments: Study protocol is available on request to Regional Committees for Medical and Health Research Ethics.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.